PMID: 9435818Jan 1, 1997Paper

Risk factors of late complications after interstitial 192Ir brachytherapy in cancers of the oral cavity

Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
D Peiffert

Abstract

Brachytherapy has confirmed its prevailing role in conservative treatment of oral cavity carcinomas. To describe late toxicity in long-term surviving patients, comparisons with other series are necessary. Study of series of patients implanted for floor of the mouth or mobile tongue shows the need for more detailed data. Dental prophylaxy and lead protection of the mandibule, good indications and techniques of brachytherapy are necessary to avoid late complications. Some treatment factors have proved to be of good prognosis for late complications through multivariate analysis of large series treated with lr 192 wires, using the Paris system, eg, dose rate lower than 0.5 or 0.7 Gy/h, intersource spacing smaller than 1.2 or 1.5 cm, treated surface less than 12 cm2, lineic activity less than 1.5 mCi/cm, less than 1 cm diameter hyperdose, and use of mandibular lead protections. Tumor volume and location to the floor of mouth lead to higher risk of complications. Knowledge of treatment-related factors is important, with the development of new afterloading projectors allowing to control the dose rate and correct small inhomogeneities. High-dose rate exclusive brachytherapy is not recommended. More precise and reproducible classificati...Continue Reading

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Related Papers

Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
M LapeyreD Peiffert
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
M LapeyreD Peiffert
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
J M SimonB Pierquin
© 2021 Meta ULC. All rights reserved